Mission Statement, Vision, & Core Values (2026) of Pfizer Limited.

Discover how Pfizer Limited - a subsidiary of Pfizer Inc. with roots in India since 1950 and a legacy stretching over 70+ years - translates its purpose, "Innovate to bring therapies to patients that significantly improve their lives," into real-world impact across a diverse therapeutic portfolio, patient-centric clinical development and community-focused CSR efforts; aligned with Pfizer Inc.'s bold vision to change 1 billion lives by 2027, the company drives operational excellence through simplification and emerging technologies while embedding its four core values - courage, excellence, equity and joy - into decisions that expand access, tackle unmet needs and shape healthcare outcomes, inviting you to read on to see the numbers, strategies and initiatives behind each pillar.

Pfizer Limited (PFIZER.NS) - Intro

• Founded in India: 1950 - over 70 years of operations
• Strategic focus: patient-centric innovation, operational excellence, simplified processes, digital transformation
• Therapeutic coverage: vaccines, oncology, cardiology, inflammation & immunology, rare disease, hospital products, primary care
• CSR & access initiatives: public health programs, vaccine access campaigns, community outreach and capacity building

• R&D collaboration: supports local and multicountry clinical development and investigator-initiated studies
• Manufacturing & supply chain: emphasis on reliability and regulatory compliance to ensure medicine availability
• Technology adoption: automation, data analytics and digital tools to simplify processes and enhance productivity

• Product portfolio: diverse portfolio across primary care, specialty and vaccines to address both acute and chronic conditions
• Clinical & regulatory engagement: active partner in Indian clinical research and regulatory pathways for new therapies
• Community reach: targeted public health and access programs aiming to improve healthcare outcomes in underserved areas

• Mission: advance health by discovering, developing and delivering innovative medicines and vaccines that improve lives
• Vision: be a premier biopharmaceutical company that transforms patient outcomes through science-driven innovation
• Core values: patient first, integrity, teamwork, excellence, courage to innovate

Pfizer Limited (PFIZER.NS) - Overview

Mission: Innovate to bring therapies to patients that significantly improve their lives.

This mission drives Pfizer Limited's patient-centric strategy, aligning with Pfizer Inc.'s global purpose of 'Breakthroughs That Change Patients' Lives.' It shapes R&D priorities, commercial focus, and daily operations across India, reinforcing a commitment to develop therapies that address unmet medical needs and improve clinical outcomes.

• Patient focus: therapies designed to improve survival, quality of life and symptom control.
• Innovation emphasis: continuous investment in clinical development and new modalities.
• Operational alignment: local commercial strategies tied to global pipeline and standards.

Vision

To be a leading biopharmaceutical company in India that translates global breakthroughs into accessible, high-quality treatments for Indian patients and healthcare systems.

• Translate global R&D into locally relevant therapies and vaccines.
• Work with providers, payers and policymakers to expand access and affordability.
• Leverage manufacturing, regulatory and distribution capabilities to ensure supply continuity.

Core Values

• Patient centricity - decisions anchored in patient benefit and safety.
• Scientific excellence - rigorous evidence generation and clinical rigor.
• Integrity - ethical conduct, regulatory compliance and transparency.
• Collaboration - partnering with clinicians, academia and government stakeholders.
• Accountability - measurable outcomes, performance and stewardship of resources.

How the Mission Translates to Measurable Actions

Key Performance Indicators Linking Mission to Business Outcomes

• Portfolio impact: share of revenues from innovative/novel therapies versus legacy products.
• Access metrics: number of hospitals, government programs and insurance formularies including Pfizer therapies.
• Safety surveillance: adverse event reporting timelines and signal-resolution metrics.
• Clinical pipeline translation: number of global programs transitioned to local registration and launch.

Pfizer Limited's strategic and operational choices reflect its mission by prioritizing therapeutic areas with high unmet need, maintaining compliance and quality standards, and leveraging Pfizer Inc.'s R&D scale. For more historical and corporate context, see: Pfizer Limited: History, Ownership, Mission, How It Works & Makes Money

Pfizer Limited (PFIZER.NS) - Mission Statement

• Core mission: develop, manufacture and deliver safe, effective medicines and vaccines that improve patient outcomes and expand access to essential therapies.
• Operational focus: translate global R&D and supply-chain capabilities into locally relevant products and programs for Indian patients, clinicians and health systems.
• Financial stewardship: balance investment in innovation with sustainable commercial performance to fund continued research and equitable access initiatives.

• Scale target: 1,000,000,000 lives - equivalent to roughly 12.5% of a global population of ~8 billion - targeted annually by 2027 through vaccines, therapeutics, and access programs.
• Global health focus: prioritize high-burden disease areas and low- and middle-income country access to maximize lives reached per dollar invested.
• Alignment: coordinated execution with Pfizer Inc.'s Purpose Blueprint 2.0 to ensure consistent metrics, shared R&D pipelines and synchronized supply/affordability strategies.

• Access & delivery initiatives - agreements, tiered pricing and partnerships targeted at expanding reach in public health programs and private markets.
• Local manufacturing & supply chain resilience - to reduce stockouts, shorten lead times and increase affordability in the region.
• Portfolio prioritization - focus resources on vaccines, anti-infectives and high-burden therapeutic areas to maximize lives impacted per program.
• Metrics & reporting - standardized KPIs (lives reached, doses delivered, patients treated, affordability indices) linked to the parent company's Blueprint for consistent measurement.

Pfizer Limited (PFIZER.NS) - Vision Statement

• Courage: challenging convention in research, regulatory engagement, and market access strategies to accelerate patient impact.
• Excellence: delivering high-quality manufacturing, clinical development, and commercial execution measured by clinical success rates and patient outcomes.
• Equity: advancing inclusive healthcare access-reducing disparities in treatment availability, pricing strategies, and community outreach.
• Joy: fostering a workplace where contributions are recognized, employee well-being is prioritized, and purpose-driven work creates fulfillment.

• Courage - fast-tracked clinical decision-making and willingness to invest in high-risk/high-reward R&D programs; measurable by time-to-first-patient-enrolled and portfolio progression rates.
• Excellence - clear KPIs across manufacturing yield, regulatory approval timelines, and commercial market share in priority therapeutic areas.
• Equity - vaccination and access programs targeting underserved regions, pricing differentials, and patient assistance utilization metrics.
• Joy - employee engagement scores, retention rates, and internal recognition program uptake.

• Invest in R&D aligned to high-burden diseases in India and emerging global threats, balancing bold scientific bets with disciplined portfolio management.
• Scale equitable access programs-tiered pricing, partnerships with government and NGOs, and patient assistance schemes to reduce disparities.
• Embed excellence through measurable outcome-based accountability: defined responsibilities, clear metrics (e.g., regulatory approvals per year, manufacturing quality indicators), and transparent reporting.
• Cultivate courage and joy by enabling psychological safety for employees to voice ideas, funding intrapreneurship, and celebrating milestones publicly and internally.

• Clinical development: faster protocol adaptations and accelerated enrollment in India to shorten trial timelines and expand local evidence generation.
• Manufacturing & supply: leveraging domestic facilities to support regional supply resilience, measured by on-time delivery rates and batch success rates.
• Access programs: number of patients supported through assistance programs, partnerships formed with state health departments, and vaccines/therapies introduced in public health initiatives.
• People & culture: employee engagement index, internal promotion rates, diversity metrics, and well-being program participation.